CYRXNCMIndustrials·Integrated Freight & Logistics#12 in industry

Cryoport, Inc.

Reports in 7d· 2026-05-04

+1.5% · 90d

$10.38

-0.21 (-1.98%)

After-Hours $10.38(+0.00)

News

(2)

April 2026

Apr 22, 20265 days agoARSIndustrials

Cryoport Files Empty Annual Report Summary Document (CYRX)

CYRXCryoport, Inc.

# 📑 What This Document Is 📜 This document is an Annual Report Summary (ARS) for Cryoport, Inc. The ARS is a high-level overview document used to summarize the most critical information from the company's full annual report filing. Normally, readers would use this summary to quickly grasp key finan

Read summaryView on SEC EDGAR

Apr 22, 20265 days agoDEF 14AIndustrials

Cryoport reports $176M revenue and details 2026 annual shareholder proposals

CYRXCryoport, Inc.

# 📜 What This Document Is This document is Cryoport, Inc.’s 2026 Proxy Statement (Form DEF 14A). 👉 Think of a proxy statement as a comprehensive 'Owner's Handbook' for the Annual Meeting of Stockholders. It explains exactly what matters are up for vote, who the directors are, and how the company h

Read summaryView on SEC EDGAR

Key Data

Market Cap$521.1M

Open$10.60

Prev Close$10.59

Day Range$10.35 – $10.79

52W Range$5.31 – $11.45

Volume242,892

P/E (TTM)—

EPS$-0.84

Dividend Yield—

Beta1.69

Profit Margin44.45%

Revenue Growth9.60%

Price Target$13.61(+31.1%)

Next Earnings2026-05-04(7d)

Analyst Ratings

Strong Buy9 analysts

Buy 8Hold 1Sell 0

About

Cryoport, Inc. provides temperature-controlled supply chain solutions in biopharma/pharma, animal health, and reproductive medicine markets worldwide. The company's Life Sciences Services segment provides temperature-controlled logistics and biostorage, bioservices and cryopreservation services within the life science industry. Its Life Sciences Products segment manufactures, and sells cryogenic freezers, cryogenic dewars, and related ancillary accessories within the life science industry through direct sales or a distribution network. The company's products include Cryoport Express Shippers; Cryoport Elite; Cryoport Express Cryogenic HV3 Shipping System; Smartpak Condition Monitoring System and Tec4Med, an IoT-based monitoring solutions; and Cryoport accessories. It also provides Cryoport BioStorage/Bioservices, such as Cryoport Systems Bioservices, including controlled temperature storage, kitting, labelling, fulfillment, sample management, drug return, and Qualified Person drug product release. In addition, the company offers IntegriCell services that comprise apheresis/leukapheresis collection, cryoshuttle transportation, cryo-process optimization, and cryopreservation services; Cryoport consulting services; MVE Fusion cryogenic system, a self-sustaining cryogenic freezer; and MVE Vario cryogenic system, a cryogenic freezer system. Further, it provides biological specimen cryopreservation storage and maintenance; archiving, monitoring, tracking, receipt, and delivery of samples; frozen biological specimens transportation; incoming and outgoing biological specimens management; and short-term logistics and engineering consulting services. The company was founded in 1999 and is based in Brentwood, Tennessee.

Industrials · Integrated Freight & Logistics

684 employees

www.cryoportinc.com